Skip to main content
Log in

The role of NCAM in remyelination

  • REVIEW
  • Published:
Neurological Sciences Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The neural cell adhesion molecule (NCAM) is expressed by myelinating precursor cells in neonatal mouse spinal cord and by remyelinating cells after chemically induced demyelination in adult mouse. It shows tempting suggestions about its possible involvement in the reparative mechanisms and the remyelination processes that take place in multiple sclerosis (MS). In fact, its levels progressively increase in the cerebrospinal fluid (CSF) of acute MS patients subjected to steroid treatment, paralleling the progressive clinical improvement after the attack. Such an increase is not found in nacute MS patients not treated with steroids nor in non-acute patients subjected to the same steroid treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 15 June 2001 / Accepted in revised form: 24 January 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Massaro, A. The role of NCAM in remyelination. Neurol Sci 22, 429–435 (2002). https://doi.org/10.1007/s100720200001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100720200001

Navigation